Department of Neurology, Department of Clinical Neuroscience, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Division of Neurology and Clinical Neurophysiology, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden.
J Clin Neurol. 2014 Apr;10(2):108-18. doi: 10.3988/jcn.2014.10.2.108. Epub 2014 Apr 23.
The etiology of small fiber neuropathy (SFN) often remains unclear. Since SFN may be the only symptom of late-onset Fabry disease, it may be underdiagnosed in patients with idiopathic polyneuropathy. We aimed to uncover the etiological causes of seemingly idiopathic SFN by applying a focused investigatory procedure, to describe the clinical phenotype of true idiopathic SFN, and to elucidate the possible prevalence of late-onset Fabry disease in these patients.
Forty-seven adults younger than 60 years with seemingly idiopathic pure or predominantly small fiber sensory neuropathy underwent a standardized focused etiological and clinical investigation. The patients deemed to have true idiopathic SFN underwent genetic analysis of the alpha-galactosidase A gene (GLA) that encodes the enzyme alpha-galactosidase A (Fabry disease).
The following etiologies were identified in 12 patients: impaired glucose tolerance (58.3%), diabetes mellitus (16.6%), alcohol abuse (8.3%), mitochondrial disease (8.3%), and hereditary neuropathy (8.3%). Genetic alterations of unknown clinical significance in GLA were detected in 6 of the 29 patients with true idiopathic SFN, but this rate did not differ significantly from that in healthy controls (n=203). None of the patients with genetic alterations in GLA had significant biochemical abnormalities simultaneously in blood, urine, and skin tissue.
A focused investigation may aid in uncovering further etiological factors in patients with seemingly idiopathic SFN, such as impaired glucose tolerance. However, idiopathic SFN in young to middle-aged Swedish patients does not seem to be due to late-onset Fabry disease.
小纤维神经病(SFN)的病因通常仍不清楚。由于 SFN 可能是晚期法布里病的唯一症状,因此在特发性多发性神经病患者中可能被误诊。我们旨在通过应用集中的调查程序揭示看似特发性 SFN 的病因,描述真正特发性 SFN 的临床表型,并阐明这些患者中晚期法布里病的可能患病率。
47 名年龄在 60 岁以下的成年人患有看似特发性纯或主要小纤维感觉神经病,接受了标准化的集中病因和临床调查。被认为患有真正特发性 SFN 的患者接受了编码酶α-半乳糖苷酶 A(法布里病)的α-半乳糖苷酶 A 基因(GLA)的基因分析。
在 12 名患者中发现了以下病因:糖耐量受损(58.3%)、糖尿病(16.6%)、酒精滥用(8.3%)、线粒体疾病(8.3%)和遗传性神经病(8.3%)。在 29 名真正特发性 SFN 患者中,有 6 名患者的 GLA 存在遗传改变,但无明显临床意义,但这一比率与健康对照组(n=203)无显著差异。GLA 基因改变的患者在血液、尿液和皮肤组织中均无明显生化异常。
集中调查可能有助于揭示看似特发性 SFN 患者的其他病因,如糖耐量受损。然而,瑞典年轻到中年特发性 SFN 似乎并非由于晚期法布里病引起。